2013 annual financial data
PharmaCyte Biotech 2013 Operating cash flow margin
Direct answer
Operating cash flow margin was -3,210.74%.
Operating income was -1,684,000 USD and net income was -1,598,000 USD.
Operating cash flow was -390,426 USD.
Get free PharmaCyte Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 12,160 USD
- Operating income
- -1,684,000 USD
- Net income
- -1,598,000 USD
- Operating cash flow
- -390,426 USD